Nasdaq Firm Invests in Decentralized Prediction Market, Impacting Solana Price Predictions

Enlivex Therapeutics, a Nasdaq-listed biotech firm, has made a bold move by investing $212 million directly into Rain token, the utility token behind the Rain decentralized prediction market on the Arbitrum network. This signifies a shift towards institutional adoption of high-utility assets in the crypto space, potentially impacting Solana price predictions. 💰